Market Cap (In SEK)
111.5 Million
Revenue (In SEK)
1.57 Million
Net Income (In SEK)
-309.43 Million
Avg. Volume
2.28 Million
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.526-3.15
- PE
- -
- EPS
- -
- Beta Value
- 2.471
- ISIN
- SE0006091997
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Jeff Borcherding
- Employee Count
- -
- Website
- https://www.immunovia.com
- Ipo Date
- 2015-12-01
- Details
- Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
More Stocks
-
8111
-
0HYACiena Corporation
0HYA
-
INNOVTECInnovative Tech Pack Limited
INNOVTEC
-
NVSEFNovartis AG
NVSEF
-
3050
-
GNC
-
3535Favite, Inc.
3535
-
0HFR